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Objectives: To quantify the contribution of patient delay, provider delay, and diversion between services to
delayed access to genitourinary medicine (GUM) clinics. To describe the factors associated with delay, and
their contribution to STI transmission.
Methods: Cross-sectional survey of 3184 consecutive new patients attending four GUM clinics purposively
selected from across England to represent different types of population. Patients completed a short written
questionnaire that collected data on sociodemographics, access, and health-seeking behaviour.
Questionnaires were then linked to routinely collected individual-level demographic and diagnostic data.
Results: Patient delay is a median of 7 days, and does not vary by demographic or social characteristics, or
by clinic. However, attendance at a walk-in appointment was associated with a marked reduction in patient
delay and provider delay. Among symptomatics, 44.8% of men and 58.0% of women continued to have sex
while awaiting treatment, with 7.0% reporting sex with .1 partner; 4.2% of symptomatic patients reported
sex without using condoms with new partner(s) since their symptoms had begun. Approximately 25% of all
patients had already sought or received care in general practice, and these patients experienced greater
provider delay.
Conclusions: Walk-in services are associated with a reduction in patient and provider delay, and should be
available to all populations. Patients attending primary care require clear care pathways when referred on to
GUM clinics. Health promotion should encourage symptomatic patients to seek care quickly, and to avoid
sexual contact before treatment.
S
ince the mid-1990s, the UK has experienced a resurgence
in the incidence of sexually transmitted infections (STIs)1 2
after the historically low levels that followed the advent of
AIDS in the early 1980s.3 This burden has created poor access to
the national network of genitourinary medicine (GUM)
clinics,4 5 despite increasing productivity and work intensity.6
Over the same period, the role of primary care in the control
of STIs has increased in prominence, with an English National
Strategy for Sexual Health and HIV aimed at increasing the
provision of STI care in the primary care setting.7–9 The strategy
proposed that all general practice (primary care) services should
provide ‘Level One’ care, including STI testing for women, and
the assessment and referral of men with STI symptoms. The
professional associations for doctors in primary care and GUM
clinics have produced joint guidelines for the management of
STIs in primary care,10 but these are not compulsory, and are
neither audited nor incentivised. A framework of
‘Recommended Standards for Sexual Health Services’11 com-
missioned by the Department of Health recommended well
defined care pathways for the treatment and follow-up of
individuals diagnosed with STIs outside the GUM clinic setting.
Tests for STIs, with the exception of microscopy, are generally
available in primary care, but are variably used.12 13 GUM clinics
treat on the basis of aetiological diagnoses, but the extent to
which this happens in primary care is unclear.
There is limited evidence on the extent to which STIs are
currently diagnosed and/or managed in primary care,13 14 and
no routine surveillance of primary care diagnoses or manage-
ment practices. Small-scale studies have suggested that up to
40% of new patients might attend their GP surgery before
attending the GUM clinic,15 while other data suggest that men
are often treated syndromically in the primary care setting.14
Patients who cannot easily access curative services for acute
STIs are at risk of prolonged periods of infectivity, which
increases the likelihood that they will further transmit their
STI.16 17 We present the results of a large-scale survey of GUM
patients with linkage to clinic data in four contrasting
geographic and health service settings, which quantifies the
contribution made by patient delay, provider delay, and
diversion between services to delayed access to GUM services,
and focuses on the potential role of delay in STI transmission.
METHODS
Population and sampling
Seven GUM clinics across England were purposively recruited,
representing contrasting demographic, geographic and service
configuration characteristics likely to affect sexual health need
and use of services. These included a London clinic, large
provincial cities with single and with multiple clinics, a city
with a substantial Asian population, and clinics serving rural
populations. These clinics operated differing access policies. All
offered some degree of triage to identify patients needing more
urgent care. Two offered the majority of their slots as ‘walk-in’
(ratios of 9:1 for men and 5:1 for women in one clinic, and 5:1
for all patients in the other clinic). Three clinics were excluded
from the analysis due to low response rates (17.8% to 24.5%),
thought to be due to reception staff not offering questionnaires
to all new patients. There was no significant difference between
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www.stijournal.com
 on 24 July 2008 sti.bmj.comDownloaded from 
these excluded clinic samples in the proportion with STI
diagnosis or other characteristics, with the exception only that
the women in the included samples were more likely to report
daily work or college, and to go the clinic from home rather
than elsewhere.
The protocol required that all new patients were given
written information about the study by the receptionist, and
invited to complete a short, 22-item self-completion written
questionnaire in English (The questionnaire is available as
supplementary material from http://sti.bmj.com/supplemental).
This questionnaire explored patients’ health-seeking behaviour
and contact with services in relation to their current pro-
blem(s). In order to protect confidentiality, questionnaires were
anonymous apart from the clinic identification number that
was used to link the questionnaire to the clinic’s routine
database to obtain patient’s gender, age, ethnicity, partial
postcode, STI diagnosis/es and whether or not the STI was
homosexually acquired.
Data collection took place from October 2004 to March 2005,
with a shorter collection period in the larger clinics. The
denominator for each clinic is estimated as the number of new
clinic numbers issued minus, if applicable, those issued in the
week in November 2004 when the Department of Health
conducted its Waiting Time Survey, as questionnaires were not
distributed during this week.18
Defining delay
We analysed delayed access to GUM clinics in terms of ‘patient
delay’ in seeking care, and ‘provider delay’. Patient delay is
defined as waiting .7 days to seek care from when symptoms
began, as this corresponds to the median for men and women.
By definition, patient delay is only applicable to patients
reporting symptoms at clinic visit and/or that their reason for
going to the clinic was because ‘I have (or have had) symptoms
(e.g. itching, discharge)’. Provider delay is defined as waiting
.4 days from first contacting any health service to being seen
at the study clinic. While arbitrary, this figure corresponds to
waiting 48 h to be seen at the study clinic, which is a
Department of Health target,19 while allowing an additional
48 h for those who try to seek care from other health settings
(e.g. general practice) and/or to allow for delays caused by clinic
access only available on weekdays. We consider these two
outcomes as binary variables.
Statistical analysis
We used the Chi-square statistic to determine statistical
significance, which is considered as p,0.05 for all analyses.
We also used logistic regression to obtain crude and adjusted
odds ratios (OR) for reporting the two delay outcomes (table 1)
and having STI(s) diagnosed at the study GUM clinic (table 2).
We entered the factors hypothesised as associated with delay
(table 1) into a multivariate logistic regression model, and used
forward stepwise selection to identify a parsimonious model of
key factors associated with a STI diagnosis. To increase the
efficiency of this model we collapsed categories where no
statistical difference in parameters was found. Analyses were
undertaken using the survey commands in STATA 8.0
(Statacorp, Texas, USA) to take account of clustering by clinic.
Ethical approval was obtained from South West Multi-Centre
Ethics Committee.
RESULTS
Sample characteristics
3685 questionnaires were completed in the four clinics
presented, of which 3184 (86.4%) could be linked to clinic
data, resulting in a sample of 1624 men and 1560 women. The
combined estimated mean response rate was 52.5%, with a
range from 41.0% to 70.1%. The demographic characteristics of
this sample are shown in the supplementary material (http://
sti.bmj.com/supplemental). Just over half (52.2%) of women
and 37.3% of men were under the age of 25, a quarter were
cohabiting, while 16.3% women and 10.4% of men had
childcare responsibilities. The sample was relatively well
educated, with over a third of respondents aged 21 or over
reporting a degree as their highest educational qualification. A
total of 93.1% of women and 87.3% of men were registered with
a general practitioner (GP). There was, as shown by the
supplementary material (http://sti.bmj.com/supplemental) and
as planned, much variation in many of the background
characteristics by clinic. There was however no evidence of
differences between new attendees who completed the ques-
tionnaire and those who did not, with respect to routinely
collected data on gender, age, ethnicity and whether or not
STI(s) were diagnosed.
Proportion with STI diagnosis/es at the study GUM clinic
Overall, 38.1% of men and 28.4% of women had at least one
acute STI diagnosed at the study GUM clinic (as defined in
table 1), a significant gender difference (p = 0.0075). These
proportions varied by clinic among men (range 31.4%–42.3%)
and women (range 24.1%–30.1%). Half (52.7%, 95% CI 47.0% to
58.3%) of the 2908 individuals answering the question on
symptoms reported having, or having had, symptoms at the
time of clinic visit. Symptomatic individuals were more likely to
have an acute STI diagnosed than others (43.8%, 95% CI 35.0%
to 53.0%, against 20.3%, 95% CI 17.2% to 23.8%, p = 0.0028).
Estimating delay
Table 1 presents comparative data on patient delay and provider
delay, along with their associations. Median patient delay was
7 days in men and women. This did not vary by age, or
ethnicity, nor according to whether the patient had STI(s)
diagnosed, or GP registration status. There was no association
with cohabitation status, childcare responsibilities, or working/
attending college during the day, and either patient delay or
provider delay. However, patients who reported attending as a
‘walk-in’ experienced substantially shorter patient delay. The
proportion of respondents reporting that they were ‘walk-in’
varied between clinics from 10.4% and 94.4% among men, and
from 9.8% to 86.1% among women.
Median provider delay was 7 days for men and for women,
although this varied substantially by clinic, from 0–21 days
overall. A total of 29.4% of all patients were seen at clinic on the
same day that they tried to contact any health professional for
their problem. In terms of the Department of Health’s targets, a
further 10.2% were seen within 48 h of contacting any health
professional, although not the same day. Just over half (51.1%)
of patients waited at least a week between first seeking care
from any health professional to being seen at the study GUM
clinic.
Provider delay was overall substantially greater among
patients reporting a booked appointment (medians of 14 days
versus 1 day, respectively), and those who had tried to use their
GP for their current problem experienced significantly longer
provider delay (medians of 10 days versus 4 days), even after
adjustment for the factors in table 1.
The duration of symptoms by the time of attending clinic is
highly variable in men and women. A total of 26.7% (95% CI
14.4% to 44.2%) of patients had been symptomatic for
,1 week, 14.4% (95% CI 6.1% to 30.2%) 7–13 days, 20.8%
(95% CI 13.3% to 31.0%) 14–27 days, 16.6% (95% CI 8.5% to
29.9%) between 4–6 weeks, and 21.5% (95% CI 5.5% to 56.4%)
over 6 weeks. The importance of delayed access to GUM
services in terms of disease control depends on what additional
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potential for STI transmission is generated by delay. This in
turn depends on the sexual behaviour and healthcare seeking
behaviour of those requiring treatment for STIs. In our sample,
44.8% (95% CI 38.0% to 51.7%) of 614 symptomatic men and
58.0% (95% CI 46.7% to 68.5%) of 617 symptomatic women
reported continuing to have sex after symptoms had begun. In
our sample, 4.2% (95% CI 2.2% to 8.0%) of 1449 symptomatic
respondents reported sex after their symptoms had begun with
at least one new partner without using condom(s).
Factors associated with STI diagnosis/es at the study
GUM clinic
An individual’s potential to transmit an STI depends on having
an STI. We therefore explored whether patients diagnosed with
STI(s) were in fact experiencing greater patient or provider
delay. However, having a STI diagnosis at the study GUM
clinic was not associated with either measure of delay. Table 2
shows that in men the presence of symptoms, and in parti-
cular worsening symptoms, is helpful in predicting which
patients are most likely to have STI(s). By contrast, in women,
having attempted to use general practice and reporting that
their symptoms had stayed the same or worsened is associated
with a higher odds ratio for STI diagnosis/es at the study GUM
clinic.
The role of general practice
We explored the role of general practice in the care pathway of
patients reporting attempting to use their general practitioner
for their STI problem (table 3). A total of 25.2% of all male and
30.9% of all female respondents reported using, or trying to use,
general practice before attending the study clinic (p = 0.196 for
gender difference). Patients who had tried general practice
were more likely to have an STI diagnosed at the study GUM
clinic than respondents who had not tried general practice
(33.3% versus 25.5%, p = 0.0072). Of the 801 patients who
reported trying to use general practice, 63.9% (95% CI 56.0% to
71.1%) reported actually seeing a health professional in this
setting. Among the 203 patients who had seen a health
professional in general practice but who were later diagnosed
with acute STI(s) at the study GUM clinic, 66.0% (95% CI 54.3%
to 76.0%) had received treatment in general practice, while
4.4% (95% CI 2.4% to 8.2%) had been advised to go to a GUM
Table 2 Key factors associated with STI diagnosis/es*, at the study GUM clinic, by gender
Row Crude OR (95% CI) Adjusted OR` (95% CI) Denominator
Men, all: 38.1% – – 1624
Age: p = 0.159 p = 0.102
16–24 38.9% 1.00 1.00 604
25–34 39.3% 1.02 (0.68–1.53) 0.99 (0.67–1.46) 603
35+ 35.0% 0.85 (0.68–1.06) 0.73 (0.53–1.01) 414
Ethnicity: p = 0.007 p = 0.002
Other ethnicity 36.7% 1.00 1.00 1485
Black Caribbean 52.5% 1.91 (1.39–2.61) 2.43 (1.87–3.16) 139
Have/had symptoms: p = 0.001 p = 0.037
No 27.2% 1.00 1.00 853
Yes 50.1% 2.68 (2.10–3.43) 2.09 (1.09–4.00) 771
Had symptoms for ,1 week: p = 0.024 p = 0.134
No 35.5% 1.00 1.00 1475
Yes 63.8% 3.20 (1.34–7.63) 1.80 (0.72–4.49) 149
Symptoms worsened since first contacted health
professional:
p = 0.001 p = 0.033
No symptoms 26.1% 1.00 1.00 766
Symptoms did not worsen (stayed the same or
improved)
41.0% 1.96 (1.47–2.63) 0.95 (0.48–1.89) 337
Symptoms worsened 53.7% 3.29 (2.59–4.17) 1.68 (0.93–3.05) 521
Women, all: 28.4% – – 1560
Age: p = 0.052 p = 0.129
16–24 32.4% 1.00 1.00 814
25–34 24.7% 0.68 (0.55–0.85) 0.70 (0.51–0.95) 494
35+ 22.6% 0.61 (0.38–0.99) 0.60 (0.30–1.17) 252
Ethnicity: p = 0.020 p = 0.038
Other ethnicity 29.0% 1.00 1.00 1488
Black African 16.7% 0.49 (0.30–0.81) 0.52 (0.29–0.94) 72
Used/tried to use general practice before going to GUM
clinic:
p = 0.003 p = 0.003
No 25.0% 1.00 1.00 1007
Yes 34.5% 1.58 (1.35–1.85) 1.39 (1.24–1.55) 553
Symptoms improved since first contacted health
professional:
p = 0.024 p = 0.037
No symptoms 18.7% 1.00 1.00 734
Symptoms improved 32.2% 2.07 (0.94–4.56) 1.74 (0.77–3.92) 633
Symptoms did not improve (stayed the same or
worsened)
52.9% 4.88 (2.96–8.06) 3.65 (2.20–6.07) 193
Self-treated symptoms: p = 0.090 p = 0.048
No symptoms 20.3% 1.00 1.00 843
Symptoms but did not self-treat 40.1% 2.63 (1.44–4.80) 1.44 (0.84–2.47) 491
Symptoms and self-treated 33.2% 1.95 (1.09–3.50) 0.98 (0.53–1.84) 226
*Acute STIs are defined as infectious syphilis (KC60 codes: A1, A2), uncomplicated gonorrhoea (KC60 codes: B1, B2), complicated gonorrhoea (KC60 code: B5),
chancroid/lymphogranuloma venereum (LGV)/donovanosis (KC60 codes: C1, C2 & C3); chlamydial infection (uncomplicated/complicated) (KC60 codes: C4a, C4b,
C4c); uncomplicated non-gonoccocal/non-specific urethritis in males (KC60 code: C4h); complicated non-gonoccocal/non-specific infection (KC60 code: C5); herpes
simplex (first attack) (KC60 code: C10a); genital warts (first attack) (KC60 code: C11a); trichomoniasis (KC60 code: C6a).
618/1624 men and 443/1560 women were diagnosed with acute STIs at the study GUM clinic.
`Parsimonious multivariate model identified through forward stepwise logistic regression. Odds ratios (OR) are adjusted for all variables significant in the parsimonious
multivariate model. Criteria for inclusion in the multivariate model is p,0.10, except for age and ethnicity (see Methods).
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clinic, and 17.7% (95% CI 12.4% to 24.7%) received both
treatment and advice to go to a GUM clinic. A further 10.3%
(95% CI 5.9% to 17.6%) reported receiving neither treatment
nor advice to go to a GUM clinic, despite having seen a health
professional in general practice.
DISCUSSION
Our data show that use of booked appointments is associated
with substantially increased patient and provider delay, and
that the 28.0% of patients who had already used/tried to use
general practice experienced longer provider delay.
It is important to acknowledge the relatively low overall
response rate that was achieved, and the exclusion of clinics
with particularly low response. We are also unable to report the
number of patients who chose to accept a later appointment
than that originally offered, a proportion that could be as high
as 20% of those offered an appointment within 48 h (George
Kinghorn, personal communication). We are unable to deter-
mine the extent to which GPs advised sexual abstinence or
partner treatment, though existing data suggest partner
notification is rarely undertaken in primary care.20 21
There is evidence of declining provision of walk-in services
since the late 1990s.5 Two studies have described the impact of
changing appointment systems. One showed an alternative to a
‘walk-in’ service, which involved two-thirds of slots being
bookable on the day only, to be equivalent to walk-in in terms
of delay and the population seen.22 Another, using the same
methodology, documented a reduction in STIs seen following a
switch from walk-in to booked appointments.23 We are not
aware of more recent studies aiming to quantify patient and
provider delay in relation to STI status. A national programme
of monitoring GUM clinic waiting times does not collect data
on disease status, or sexual behaviour, and does not explore use
of other services in detail. It shows that there have recently
been modest declines in GUM clinic waiting times.24 A number
of clinics have published studies of access related factors. Data
from a recent study in one clinic suggest that it was meeting
only a quarter of demand.25 Staff at one clinic that records all
calls have estimated that only 25% of those who fail to attend
their booked GUM clinic appointment will rebook within a
month, and that rebooking is less common among teenagers
(George Kinghorn, personal communication).
Our data demonstrate that inadequate access to GUM clinic
services, and in particular to walk-in clinics, along with
substantial rates of informal diversion from primary care
following variable degrees of management, are important
contributors to delayed access to care and thus to preventable
STI transmission in the UK. Modelling work, and estimates of
unmet demand from other clinics suggest that this is likely to
be a major determinant of rising STI rates in the UK.26 Our
study demonstrates that known substantial variation in provider
delay18 24 27 between clinics is not explained by difference in
patients’ healthcare seeking behaviour, which vary little by clinic
and by demographic characteristics. The association of walk-in
appointment use with reduced patient delay and reduced
provider delay suggests potential benefit in terms of reducing
patients’ period of infectivity. This in part reflects a selection
effect (in that those individuals most capable of negotiating fast
access tend to choose walk-in appointments where available).
However, it also suggests that greater availability of walk-in slots
can be expected to reduce patient and provider delay at the
population level. Given the decline and variability in walk-in
services seen in our study and reported elsewhere,5 this suggests
that a move away from open access can be expected to increase
delay and thus STI transmission.
The quality of management in primary care has the potential
for major impact on STI transmission in the UK, as a quarter of
patients of both genders in this study, in all locations, first
sought care from their GP for their suspected STI. Analysis of a
large primary care database showed that large numbers of men
are treated in general practice for symptoms of presumptive
STI, with very few cases of chlamydia actually diagnosed.14 If,
as also suggested by our data, such cases are treated
presumptively in general practice with patients nonetheless
advised to go to a GUM clinic for a more thorough check-up,
then patients who do not go or can not access the clinic (e.g.
because of waiting times) might assume that they have been
‘cured’ of their infection, when in reality, some still risk onward
transmission and/or re-infection. Further work to determine
the extent of correct treatment is needed. There is evidence that
individuals diagnosed with chlamydia in primary care are less
likely to have an HIV test than those diagnosed in GUM
clinics.28 However, it should be noted that some respondents,
especially those who did receive some treatment in primary
care, might report being advised to go to a GUM clinic when
they were in fact told to do so if their symptoms did not
disappear or returned, rather than specifically in terms of that
episode. In-depth analyses of primary care databases suggest
that increasingly general practice is appropriately treating
people diagnosed with chlamydia, with the proportion with
evidence of appropriate therapy increasing from approximately
one-quarter in 1995 to three-quarters in 2004, while there has
Table 3 Experience of general practice before going to the study GUM clinic, by gender
Men Women p Value for gender difference
Denominator* 359 442
Went to general practice in person 70.8% 66.7% p = 0.041
Saw health professional(s) in general practice 66.3% 62.0% p = 0.226
Denominator 238 274
Health professional seen in general practice: p = 0.035
Doctor 5.0% 15.3%
Nurse 62.2% 48.5%
Doctor and nurse 14.3% 15.7%
None reported (but reported being prescribed
treatment)
18.5% 20.4%
General practice’s management of patient: p = 0.115
Prescribed treatment 65.5% 57.8%
Advised to go to a GUM clinic 3.4% 8.2%
Prescribed treatment and advised to go to a GUM
clinic
22.8% 23.9%
Neither outcomes reported 8.2% 10.1%
*Denominator is those respondents with evidence of using (or trying to use general practice) before going to the study
GUM clinic.
Denominator is those reporting to have seen at least one health professional in general practice.
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been a corresponding decline in the proportion referred to a
GUM clinic.29
A lack of formal and fast referral to GUM clinics, or the
capacity for complete STI management in the primary care
setting, together leave many patients at risk of failing to obtain
curative treatment and without means of ensuring appropriate
treatment for their sexual partner(s). Given the high volume of
patients who present first to primary care, it is essential that the
commissioning of STI services care pathways as required in the
‘Recommended Standards’11 requires that either fast-track
referral to a GUM clinic or other specialist services, or adequate
testing and treatment in the initial setting, is provided at the
first point of contact. There is a need for greater flexibility in
clinic hours, which rather than invalidating our findings,
suggest that STI control could require improving the immediate
accessibility of services as well as increasing their capacity.
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